Featured Editorial
-
Putting Vaccine Supply Resilience To The Test: The Last Mile
4/29/2026
This second in a two-part series describes how the resilience of a global vaccine network shaped clinical supply is challenged up to the last mile: at clinical sites.
-
How Clinical Supply Drives Resilience In Global Vaccine Networks
4/29/2026
This article is the first in a two-part series exploring how clinical supply's ability to integrate processes drives resilience in global vaccine programs.
-
From Inconsistency To Structure: A Model For Defensible Compliance Decisions
4/29/2026
Compliance decisions depend on how sponsors, manufacturers, logistics, and brokers align inputs. Structure connects documentation, reducing reconstruction at review.
-
Building Resilient Clinical Supply Chains To Keep Trials On Track
4/27/2026
Global trials fail when supply cannot adapt. See how IRT signals, dynamic forecasting, and risk triggers keep inventory aligned, prevent stockouts, and protect timelines.
-
Randomization And Trial Supply Management (RTSM) Systems: Meet Your Neighbor Again
4/24/2026
RTSM is evolving into a precision engine for clinical supply, aligning real-time trial activity with smarter planning, lower waste, and faster operational decisions.
-
Real-World Data Is Reshaping How We Supply Clinical Trials — And It's About Time
4/23/2026
Real-world data is transforming clinical trial supply planning by improving forecasting, reducing waste, and enabling faster, leaner, more efficient trials.
-
Why Good Data Still Fails: Inconsistency, Visibility, And Decision Risk
4/22/2026
Even with strong visibility clinical supply chains face delays when data is inconsistent across systems. Alignment not more data drives faster, clearer border decisions.
-
Designing CNS Trial Supply Chains: A Technical Framework
4/21/2026
CNS trials demand precision supply chains. From DTP logistics to dynamic forecasting, small disruptions can compromise data, adherence, and outcomes.
-
Primary Healthcare Disruption And Clinical Trial Supply Risk
4/20/2026
Funding cuts are destabilizing primary healthcare systems and exposing hidden risks in clinical trial supply, from cold chain breakdowns to site readiness gaps.
-
Protecting Clinical Trials From Global Supply Disruptions
4/17/2026
Clinical trials are fragile. Supply chain disruptions like cold chain failures or single-source dependencies threaten patient safety and trial success.